McKesson Corporation – Consensus Indicates Potential 19.2% Upside
McKesson Corporation found using ticker (MCK) now have 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 395 and 320 with the average target price sitting at 368.92. Now with the previous closing price of 309.38 this would imply there is a potential upside of 19.2%. The 50 day moving average now sits at 320.72 and the 200 day MA is 261.91. The market cap for the company is $44,661m. You can visit the company''s website by visiting: https:||www.mckesson.com [stock_market_widget type="chart" template="basic" color="green" assets="MCK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $53,256m based on the market concensus. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.
McKesson Corporation – Consensus Indicates Potential 19.2% Upside
McKesson Corporation found using ticker (MCK) now have 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 395 and 320 with the average target price sitting at 368.92. Now with the previous closing price of 309.38 this would imply there is a potential upside of 19.2%. The 50 day moving average now sits at 320.72 and the 200 day MA is 261.91. The market cap for the company is $44,661m. You can visit the company''s website by visiting: https:||www.mckesson.com [stock_market_widget type="chart" template="basic" color="green" assets="MCK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $53,256m based on the market concensus. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.